The burden of diurnal and nocturnal gastroesophageal reflux disease symptoms
- PMID: 22098290
- DOI: 10.1586/erp.11.72
The burden of diurnal and nocturnal gastroesophageal reflux disease symptoms
Abstract
Aims: To quantify the relationship between the timing of gastroesophageal reflux disease (GERD) symptoms and the burden of illness.
Patients & methods: Data from the 2010 National Health and Wellness Survey were used. Regression analyses compared non-GERD controls with GERD patients with diurnal symptoms, nocturnal symptoms, and both diurnal and nocturnal symptoms, controlling for potential confounders. Outcome measures included the Work Productivity and Activity Impairment and Short Form-12 questionnaires and reported healthcare resource use.
Results: All GERD groups demonstrated a substantial burden of illness compared with controls, estimated at US$1435 in direct costs and US$3143 in lost productivity. Experiencing GERD both day and night was associated with higher costs and lower quality of life than experiencing diurnal-only or nocturnal-only symptoms.
Conclusion: Experiencing GERD symptoms both day and night is associated with higher costs than experiencing diurnal or nocturnal symptoms alone.
Similar articles
-
Gastroesophageal reflux disease: impact on work productivity and daily-life activities of daytime workers. A French cross-sectional study.Dig Liver Dis. 2013 Mar;45(3):200-6. doi: 10.1016/j.dld.2012.11.005. Epub 2012 Dec 10. Dig Liver Dis. 2013. PMID: 23238032
-
Effects of gastroesophageal reflux disease on sleep and outcomes.Clin Gastroenterol Hepatol. 2009 Sep;7(9):953-9. doi: 10.1016/j.cgh.2009.04.005. Epub 2009 Apr 16. Clin Gastroenterol Hepatol. 2009. PMID: 19375520
-
Relationship between symptom load of gastro-oesophageal reflux disease and health-related quality of life, work productivity, resource utilization and concomitant diseases: survey of a US cohort.Aliment Pharmacol Ther. 2008 May;27(10):960-70. doi: 10.1111/j.1365-2036.2008.03671.x. Epub 2008 Feb 29. Aliment Pharmacol Ther. 2008. PMID: 18315585
-
Review article: impact of night-time reflux on lifestyle - unrecognized issues in reflux disease.Aliment Pharmacol Ther. 2004 Dec;20 Suppl 9:3-13. doi: 10.1111/j.1365-2036.2004.02237.x. Aliment Pharmacol Ther. 2004. PMID: 15527460 Review.
-
Review of the quality of life and burden of illness in gastroesophageal reflux disease.Dig Dis. 2004;22(2):108-14. doi: 10.1159/000080308. Dig Dis. 2004. PMID: 15383750 Review.
Cited by
-
Phase 4 Study in Patients From Asia With Gastroesophageal Reflux Disease Treated With Dexlansoprazole.J Neurogastroenterol Motil. 2020 Jan 30;26(1):85-95. doi: 10.5056/jnm19031. J Neurogastroenterol Motil. 2020. PMID: 31597230 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical